Eric D. Tetzlaff

MedicineHealth ProfessionsEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).”.

SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11544

N/A

0.396DataRank · unranked

13 citations

Margaret von Mehren, Elizabeth A. Handorf, Jeffrey A. Morgan, Michael J. Nathenson, Katherine A. Thornton +10 more

Burnout among oncology physician assistants (PAs) from 2015 to 2019.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11009

N/A

0.208DataRank · unranked

3 citations

Heather M. Hylton, Karen Ruth, Zachary Hasse, Michael J. Hall, Eric D. Tetzlaff